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doi:10.1016/j.ejvs.2010.03.010Abstract Heterotopic ossification (HO) is the formation of bone outside the skeletal system,
including old incisions. Although a well-known complication after orthopaedic surgery, it is still
considered an uncommon phenomenon after vascular surgery. Recent data, however, show
that up to 25% of all patients develop HO after midline abdominal surgery. In this article,
we present the case of a symptomatic HO, 7 years after an aortobiiliac prosthetic reconstruc-
tion for an abdominal aortic aneurysm. Furthermore, we review current insights into the aeti-
ology and show bone morphogenetic proteins to play a crucial role. Treatment options are also
reviewed, but lacking any supportive evidence for other therapies, surgical excision with
primary closure is the treatment of choice.
Crown Copyright ª 2010 Published by Elsevier Ltd on behalf of European Society for Vascular
Surgery. All rights reserved.Introduction
Heterotopic ossification (HO) is the formation of bone
outside the skeletal system, which can occur in all kinds of
soft tissues. It may ultimately lead to severe disabilities in
daily life, depending on the structures involved. In ortho-
paedic surgery, it is a frequently reported phenomenon
after joint surgery, although the pathogenesis has not been
clarified yet. In midline abdominal surgery, such as aortic43 3881497; fax: þ31 43
cher@gmail.com (M.H.F.
10 Published by Elsevier Ltd on berepair, the formation of HO is still considered an uncommon
complication. Recent data, however, estimate that 25% of
all patients after midline abdominal surgery develop HO.1
In this study, we present a symptomatic case of a large
vertically aligned HO, 7 years after implantation of an
aortobiiliac prosthetic reconstruction for an abdominal
aortic aneurysm. Furthermore, we review the aetiology and
treatment options of HOs.
Case
A 64-year-old male presented with an 18-month history of
progressive upper abdominal and back pain disturbing his
daily life and sleeping pattern. He had received an aorto-
biiliac prosthetic reconstruction for an abdominal aortichalf of European Society for Vascular Surgery. All rights reserved.
156 P.G.L. Koolen et al.aneurysm 7 years earlier. The pain could be triggered by
bending forward. No other symptoms were present. Except
for a solid mass in the midline abdominal scar, which was
painful on palpation, further physical examination showed
no abnormalities. A computed tomography (CT) scan
revealed a longitudinal ossification in the linea alba with
the same density as other bony structures, extending from
the xiphoid process towards the umbilicus. (Fig. 1)
Combined corticosteroids and lidocaine injections
resulted in a clear decrease in pain lasting for several days
only. Because of the mere temporal relief of symptoms,
informed consent was obtained to perform surgical resec-
tion of the abdominal mass.
At operation, the mass was found in close contact to,
but not merged with, the xiphoid. (Fig. 2) After excision,
a polypropylene mesh was used in the preperitoneal space
to cover the resulting 2 cm defect where the HO hadFigure 1 Computed tomography revealed a longitudinal
ossification (encircled) in the linea alba, sagittal (a) and obli-
que (b) view.
Figure 2 Frontal (a) and lateral (b) view of the heterotopic
ossification (c) in the upper midline abdominal scar.grown together with the rectus sheath. Caudally from the
umbilicus, a second, smaller calcified tumour was
removed.
Besides slow bowel recovery, possibly related to opiate
analgetics, the postoperative course was uneventful.
Twelve months after surgery, the patient was still free from
any signs or symptoms related to his former ossification.
Histopathology of the resected specimen revealed
a 17.4  4.3  0.9 cm mass, composed of a thin cortex and
trabecular bone of the lamellar type, with some level of
fibrosis. The intra-trabecular space consisted of fat tissue
and normally developing bone marrow with no signs of
malignancy (Fig. 3).
Methods
To systematically review the current treatment options, we
performed a systematic search through PubMed. We
included studies in the English language with data on the
treatment of HO after abdominal surgery and comprising 10
or more patients. Studies on the subject of progressive
ossifiying myositis were excluded as this form of HO is an
inherited condition in which the ossification can occur
without any prior injury.
Figure 3 The specimen showed a thin cortex and trabecular
bone of the lamellar type with some fat tissue (hematoxylin
and eosin, magnification 40).
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The following databases were comprehensively searched:
MEDLINE Advanced and PubMed. The search strategy
comprised the following MeSH headings or keywords:
(‘heterotopic ossification’ or ‘heterotopic calcification’ or
‘heterotopic bone’ or ‘Ossification, Heterotopic [Mesh]’)
and (‘abdominal’ or ‘scar’). Studies were downloaded into
a citation manager and duplicates were deleted. The
studies were identified by title and abstract and screened
by the authors to assess whether they met the selection
criteria as mentioned above. Cross-references, which were
found relevant to the subject, were added.
Results
Of 154 potentially relevant records identified, 43 were
related to HO in abdominal scars of which one was a dupli-
cate publication. As many as 34 of these studies were
excluded because they described one or several case
reports, and eight because they involved animal research.
There were no randomised controlled trials. None of the
studies reviewed met our inclusion criteria.
Discussion
HO is the formation of bone outside the skeletal system,
which can occur in all kinds of soft tissues such as skin, scars,
subcutaneous fat and muscle as well as mesenterial tissue
after intra-abdominal surgery.2e6 HO can lead to pain,
swelling, limited joint mobility and, depending on the
structures involved, may lead to severe disabilities in daily
life. There is a wide variability in the extent of the ossifica-
tions, ranging from a few millimetres to many centimetres.
HO is a well-known phenomenon in orthopaedic surgery.
About 2e7% of all patients develop extensive heterotopic
bone after hip surgerywith involvement of the capsule of the
hip joint.7,8 The exact pathogenesis of this high prevalence
after hip arthoplasty is unknown, but surgical trauma to soft
or bone tissue appears to induce an inflammatory cascade,which may lead to the formation of HO. Mechanical factors,
such as high forces on the hip joint,may also play a role in this
process. However, not all patients suffer from symptoms.
Even though it is a well-known complication after
orthopaedic surgery, it is still considered an uncommon
phenomenon after vascular or other abdominal surgery. For
vascular surgery in particular, it seems that HO occurs
mainly in traumatic amputees and is exceedingly rare in
non-traumatic amputations. Potter et al. published a study
about the formation of HO following traumatic and combat-
related amputations, which showed 62.9% of the investi-
gated residual limbs to form mild to severe HO.9 In
contrast, there exists only one documented case of HO in
an adult non-traumatic amputee.10
In a recent study, the postoperative CTs of 152 consec-
utive patients, who underwent abdominal incisions, were
analysed, showing HO in 25% of these patients.1 Unfortu-
nately, no definitive data on the associated symptoms in
abdominal incisions are available, but it is believed to be
limited to only a small subgroup of patients.
Despite the lack of extensive epidemiological studies, it
is clear that HOs are predominantly formed in males (89%),
age distribution ranging from 18 to 81 years.11,12 Most cases
occur within the first year after surgery, are self-limiting
and even go into regression.1 However, cases have been
described as occurring up to 30 years post-surgery.13
On clinical examination, patients usually present with
a palpable mass and loss of movement in the afflicted
area.14 When suspicion of HO rises, radiological imaging is
warranted. A plain X-ray, ultrasonography, CT or magnetic
resonance (MR) can be used. Radiologically, care must be
taken to differentiate between this, mostly benign, entity
and other postoperative complications (e.g., wound infec-
tion or a retained foreign body) or abnormalities.1
Although rare, complications of HO can occur. Several
case reports show the HO to start functioning as a separate
‘organ’, because of bone marrow in the excised HO, with
histological evidence of normal trilineage haematopoi-
esis.15 Cases of osteochondroma of the xyphoid appendix
into an abdominal wall scar have also been documented.16
Despite the primary benign character of HO, malignant
transformation to osteosarcoma has also been described in
a few cases.17 Furthermore, mature lesions may fracture
after direct trauma.18,19
Aetiology
The exact pathogenesis of heterotopic bone formation is
a process, which still remains unclear. For example, blood
levels of calcium and phosphorus remain undisturbed in the
process of HO formation.2 The pathogenesis is probably
multifocal and several theories have been proposed. Older
studies suggest that vertical incisions in the proximity of
the xiphoid process or the pubic symphysis will inoculate
periosteal or perichondrial cells. This ‘seeding’ of the
surgical wound with activated osteoprogenitor cells can
therefore induce formation of heterotopic bone. Yet, many
cases have been described in which HO have occurred
without the involvement of a midline incision. Further-
more, no clarification is available about the development of
HO in patients with burn scars and non-healing ulcers.20 On
the other hand, the apparently higher incidence of HO
158 P.G.L. Koolen et al.formation in traumatic amputees might be explained by an
alternative reading of ‘seeding’. In these patients, bone
fragments may tend to be quite large and be left behind
after debridement in an otherwise non-vascular compro-
mised region.
Another theory put forward is that immature pluripotent
mesenchymal cells, localised in muscle tissue, differentiate
into osteoblasts or chondroblasts and induce bone formation
subsequently. This process is called osteogenic induction.4,21
Differentiation of (mesenchymal) cells occurs in response to
a certain (mechanical) stimulus or a combination of multiple
stimuli. This may lead to avulsion of periosteal particles from
the sites of muscular insertion to the bone.22 However, this
theory remains inadequate and unlikely.
Another stimulus might be of humoral or hormonal
nature. Prostaglandins are believed to play a key role in the
formation of heterotopic calcifications. Pluripotent
mesenchymal stem cells, for example, osteoblasts,
together with osteoclasts, regulate bone formation and are
both regulated by prostaglandins. Experimental studies in
rats show a specific subtype, prostaglandin E2, as a dose-
dependent inducer of periostal lamellar bone formation.23
Treatment with non-steroidal anti-inflammatory drugs
(NSAIDs), which act as non-selective inhibitors of the
enzyme cyclooxygenase, shows no significant advantage
compared to a conservative treatment.24 Placement of
abdominal sutures, and slowly absorbable sutures in
particular, may result in a process of chronic inflammation.
A cascade of biochemical events is induced, which, in turn,
might lead to the formation of HO.
Further, bone morphogenetic proteins (BMPs) are known
for their involvement in several phases of osteogenesis and
chondrogenesis. In a study by Shore et al., it was shown that
specific gene mutations cause constitutive activation of the
BMP type 1 receptor.25 These results were recently confirmed
by Yu et al., when the application of selective BMP type 1
receptor kinases inhibited the effectors of the BMP signalling,
resulting in less HO in fybrodysplasia ossificans progressiva.26
These findings support the critical role of BMPs in the forma-
tion of heterotopic bone and make this concept most prom-
ising for future directions of research and treatment.27
Treatment and prevention
As for current treatment options, no scientifically sound data
are available for HO in abdominal scars. Yet, severalmethods
for its treatment have been proposed. Surgical excision with
primary closure is the treatment of choice for HO. It should,
however, be restricted to patients with symptomatic ossifi-
cations.14,21 Although recurrences are unusual, immature
bone tissue tends to grow back after excision.28 Therefore,
only mature ossifications are advised to be removed.
Additional forms of treatment are mainly effective in
the prevention of HO recurrence. Radiation therapy
remains a much-discussed topic, as it is broadly used as
a way of prevention as well as treating HO after ortho-
paedic surgery.29 In abdominal surgery, however, clear
evidence for the advantage of radiation therapy is lacking,
making it controversial.21
NSAIDs, such as indomethacin, and diphopsphates,
especially etidronate disodium, are widely used in HO.24
Animal studies regarding the preventive effect of thesepharmaceutical agents, in which demineralised bone matrix
was inserted in the abdominal muscle to induce HO, have
been claimed to delay and partially prevent postoperative
recurrence of HO.30,31 However, an increasing number of
studies fail to demonstrate NSAIDs or diphosphates as an
effective treatment.23 Moreover, a Cochrane review on the
use of bisphosphates in the prevention of HO states that
given the absence of long-term radiographic outcomes in
the included studies, there is insufficient evidence to
recommend the use of disodium etidronate or other phar-
maceutical agents for the early treatment of HO.32
Conclusion
We reported the case of a 64-year-old male with chronic
invalidating abdominal pain, 7 years after a bifurcation
prosthesis for an aortic abdominal aneurysm. A 17.4-cm HO
under the midline scar was excised leading to a relief of
symptoms.
Although HO is commonly perceived as a rare compli-
cation of vascular and abdominal surgery, it actually occurs
in about 25% of midline incisions. Fortunately, only few
patients are symptomatic. New findings in the pathogenesis
of HO show bone morphogenetic proteins to play a critical
role in this process and might prove a useful target for new
therapies. As drug and radiotherapy fail as a sufficient
treatment, excision is the treatment of choice. Until
further validated research about the treatment of HO has
been published, we recommend the reader to use surgical
excision as the treatment of choice.
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